Covid vaccine produced in Africa is being exported to Europe

It is speculated that Johnson & Johnson’s Covid vaccine is one of the most necessary weapons in Africa to fight the coronavirus.

The New Jersey-based company agreed to promote enough cheap single-shot vaccines to eventually vaccinate one-third of the continent’s residents. This vaccine can be partly produced by South African producers, which makes people hope that these vaccines will quickly enter the hands of Africans.

That didn’t happen.

South Africa still needs to be ready to receive the vast majority of the 31 million doses of vaccine it has ordered from Johnson & Johnson. It manages only about 2 million photos of Johnson & Johnson. This may be a key reason, less than 7{7d6bb1f761e691f027164c9fe6d1ebbc4659a250013ce39dc45a15ede39dbac5} of South Africans are fully vaccinated-and the country was destroyed by the Delta variant.

According to executives from Johnson & Johnson and South African producer Aspen Pharmacare, at the same time:

Johnson & Johnson has been exporting hundreds of thousands of drugs bottled and packaged in South Africa for distribution in Europe. The export data of the South African authorities are reviewed by the New York occasion.

Dr. Glenda Gray, a South African scientist who helped lead Johnson & Johnson’s medical trials there, mentioned that companies want to give priority to poorer countries that worry about their manufacturing.

Johnson & Johnson has been considering selling some of the vaccines produced by Aspen to Africa, but it has never revealed the number of vaccines it actually exports.

The export data reviewed by The Occasions showed that Johnson & Johnson shipped 32 million doses this month, although this did not capture the entire volume leaving South Africa.

South Africa’s shortcomings partly show the imbalance

Critics say that South Africa’s shortcomings partly show the imbalance in influence between large companies and determined nations.

The image of the entire continent is bleak. Last week, some African countries received small-scale initial shipments of the Johnson & Johnson vaccine, but it is only a small part of the 400 million doses that the African Union has ordered or may choose to order for its member states. Approximately 2{7d6bb1f761e691f027164c9fe6d1ebbc4659a250013ce39dc45a15ede39dbac5} of Africans are fully vaccinated.

Read Also: Justin Trudeau calls for early elections in Canada

According to Johnson & Johnson and Aspen executives, some doses of Aspen have never been purchased due to concerns that they may be contaminated in the Baltimore plant that processed the first stage of manufacturing.

The plant’s problems, operated by Emergent BioSolutions, caused severe damage to Johnson & Johnson’s vaccine supply, causing the company to fall behind in orders around the world.

Latest News:

Leave a Comment